Add BrightSurf on Google Email

Molecular atlas of small cell lung cancer reveals unusual cell type that could explain why it’s so aggressive

Researchers at Memorial Sloan Kettering Cancer Center have developed a molecular atlas of small cell lung cancer, revealing a rare population of stem-like cells that correlate with patient outcomes. These cells have metastatic properties and are found across many SCLC tumors, suggesting they may be driving the disease's aggressiveness.

SourceMemorial Sloan Kettering Cancer Center·JournalCancer Cell·TypeExperimental study·DateOct 14, 2021

Catching malaria evolution in the act

Scientists have developed a technique to sequence individual malaria parasites' genomes, allowing for the detection of new mutations. These mutations are often targeting a gene family controlling transcription in malaria, suggesting potential avenues for developing more effective treatments and vaccines.

SourceTexas Biomedical Research Institute·JournalCell Host & Microbe·DateOct 13, 2021

How sepsis need not be fatal

A team of scientists has identified molecular biomarkers associated with sepsis, which could be used to predict patient outcomes and guide treatment. The study found that changes in CD52 expression were linked to good outcomes, while S100A9 acted as a driver of fatal sepsis.

SourceUniversity of California - Riverside·JournalJournal of Leukocyte Biology·TypeData/statistical analysis·DateSep 29, 2021

When organoids meet coronaviruses

Researchers have established an organoid biobank to search for genes essential for SARS-CoV-2 replication and spread. The study identified TMPRSS2 as a potential therapeutic target for the coronavirus, with specific inhibitors recently developed.

SourceHubrecht Institute·JournalNature Communications·TypeExperimental study·DateSep 17, 2021

A novel method to characterize genes with high-precision in single cells

Researchers have developed a novel method to precisely detect and characterize genes in individual cells, enabling selective enrichment of selected molecules. This approach, called BART-Seq, addresses the challenge of detecting low-abundance gene transcripts and has potential applications in disease diagnosis and precision gene-editing.

Speeding up single-cell genomics research

Researchers at Harvard University have developed a new platform for rapid single-cell sequencing, combining microfluidics and novel software to scale up single-cell ATAC-seq. This approach enables the analysis of gene control in individual cells, revealing new insights into cell development and disease processes.

SourceHarvard University·JournalNature Biotechnology·DateJun 24, 2019

Data published in Nature Methods demonstrate breakthrough ability to accurately detect somatic single nucleotide variations in single cells

A new single-cell sequencing method, AccuSomatic Amplification for Single Cell Sequencing, has been developed to accurately detect somatic single nucleotide variations in single cells. This breakthrough technology eliminates errors in somatic SNV calls while maintaining detection sensitivity.

SourceSingulOmics Corporation·JournalNature Methods·DateMar 20, 2017

Single cells seen in unprecedented detail

Researchers have developed a large-scale sequencing technique called Genome and Transcriptome Sequencing (G&T-seq) that reveals the unique genome sequence of a single cell and the activity of genes within that cell. The study found that when a cell loses or gains a copy of a chromosome, the genes in that region show decreased or in...

SourceWellcome Trust Sanger Institute·JournalNature Methods·DateApr 27, 2015

Single-cell genome sequencing gets better

Researchers at UC San Diego have developed a new single-cell genome sequencing technique that confines genome amplification to fluid-filled wells with a volume of just 12 nanoliters. This approach enables the generation of more complete genome sequences from single cells, including E. coli and individual neurons from the human brain.

SourceUniversity of California - San Diego·JournalNature Biotechnology·DateNov 10, 2013